JP2018510153A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018510153A5 JP2018510153A5 JP2017548049A JP2017548049A JP2018510153A5 JP 2018510153 A5 JP2018510153 A5 JP 2018510153A5 JP 2017548049 A JP2017548049 A JP 2017548049A JP 2017548049 A JP2017548049 A JP 2017548049A JP 2018510153 A5 JP2018510153 A5 JP 2018510153A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- pharmaceutical composition
- active agent
- roflumilast
- pde4b2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562136115P | 2015-03-20 | 2015-03-20 | |
| US62/136,115 | 2015-03-20 | ||
| PCT/US2016/023475 WO2016154143A1 (en) | 2015-03-20 | 2016-03-21 | Compositions and methods for treating copd and other inflammatory conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018510153A JP2018510153A (ja) | 2018-04-12 |
| JP2018510153A5 true JP2018510153A5 (enExample) | 2019-05-09 |
| JP6960855B2 JP6960855B2 (ja) | 2021-11-05 |
Family
ID=56979181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017548049A Expired - Fee Related JP6960855B2 (ja) | 2015-03-20 | 2016-03-21 | Ｃｏｐｄ及びその他の炎症状態を治療するための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11045456B2 (enExample) |
| EP (1) | EP3270921A4 (enExample) |
| JP (1) | JP6960855B2 (enExample) |
| CN (1) | CN107427500A (enExample) |
| HK (1) | HK1247123A1 (enExample) |
| WO (1) | WO2016154143A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021500861A (ja) * | 2017-09-27 | 2021-01-14 | ユニバーシティ オブ サザン カリフォルニア | 共刺激のための新規のプラットフォーム、新規のｃａｒ設計、および養子細胞療法のための他の増強 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005020958A2 (en) * | 2003-08-26 | 2005-03-10 | Research Development Foundation | Aerosol delivery of curcumin |
| TW200800997A (en) * | 2006-03-22 | 2008-01-01 | Astrazeneca Ab | Chemical compounds |
| US20100316631A1 (en) * | 2006-10-19 | 2010-12-16 | The Uab Research Foundation | Water Soluble Curcumin-Based Compounds |
| US20100074897A1 (en) * | 2006-12-01 | 2010-03-25 | University Of Utah Research Foundation | Methods and Compositions related to HIF-1 alpha |
| AU2009321723A1 (en) * | 2008-12-05 | 2010-06-10 | Intermed Discovery Gmbh | Inhibitors of HIF-1 protein accumulation |
| US20130172303A1 (en) * | 2012-01-03 | 2013-07-04 | Forest Laboratories Holdings Ltd. | Roflumilast compositions for the treatment of copd |
| US9951335B2 (en) * | 2012-04-10 | 2018-04-24 | Georgia State University Research Foundation, Inc. | Compositions and methods for treating otitis media and other conditions with inhibitors of CYLD |
-
2016
- 2016-03-21 HK HK18106856.0A patent/HK1247123A1/zh unknown
- 2016-03-21 CN CN201680016932.2A patent/CN107427500A/zh active Pending
- 2016-03-21 JP JP2017548049A patent/JP6960855B2/ja not_active Expired - Fee Related
- 2016-03-21 WO PCT/US2016/023475 patent/WO2016154143A1/en not_active Ceased
- 2016-03-21 US US15/559,728 patent/US11045456B2/en not_active Expired - Fee Related
- 2016-03-21 EP EP16769518.8A patent/EP3270921A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015517489A5 (enExample) | ||
| JP2017528507A5 (enExample) | ||
| JP2012502037A5 (enExample) | ||
| JP2015057436A5 (enExample) | ||
| JP2010132695A5 (enExample) | ||
| JP2017528503A5 (enExample) | ||
| JP2016516808A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| JP2012517987A5 (ja) | 吸入用の医薬組成物のｆｐｄ特性を設定する方法 | |
| JP2012176990A5 (enExample) | ||
| JP2018507914A5 (enExample) | ||
| JP2011144201A5 (enExample) | ||
| AR067639A1 (es) | Medicamentos pulverulentos que contienen tiotropio y salmetrol, asi como lactosa como excipiente | |
| JP2013518107A5 (enExample) | ||
| JP2013126989A5 (enExample) | ||
| JP2018537507A5 (enExample) | ||
| JP2014510064A5 (enExample) | ||
| JP2015534562A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| DOP2014000271A (es) | Nueva forma de dosificacion y formulacion de abediterol | |
| JP2015517983A5 (enExample) | ||
| JP2016511753A5 (enExample) | ||
| JP2015510916A5 (enExample) | ||
| JP2009542581A5 (enExample) | ||
| JP2017222722A5 (enExample) |